These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18918807)

  • 1. N-bromosuccinimide as a dehydrogenating agent.
    BARNES RA
    J Am Chem Soc; 1948 Jan; 70(1):145-7. PubMed ID: 18918807
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interaction of DNA with N-bromosuccinimide. G+C-specific reaction potentially useful for structural and functional studies].
    Sverdlov ED; Kalinina NF
    Bioorg Khim; 1983 Apr; 9(4):561-3. PubMed ID: 6679777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-bromosuccinimide assay of penicillins and cephalosporins.
    Alicino JF
    J Pharm Sci; 1976 Feb; 65(2):300-1. PubMed ID: 1255469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluorescence reaction of Amidepine with N-bromosuccinimide].
    Peterková M; Matousová O; Ryska M; Koruna I; Rejholec V
    Cesk Farm; 1988 May; 37(4):159-61. PubMed ID: 3396087
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxidimetric determination of glutathione using N-bromosuccinimide.
    Sahni MK; Sharma IK; Narang CK; Mathur NK
    Indian J Biochem Biophys; 1976 Sep; 13(3):309-10. PubMed ID: 1010582
    [No Abstract]   [Full Text] [Related]  

  • 6. Cleavage of human serum transferrin with N-bromosuccinimide.
    Bezkorovainy A; Grohlich D; Sly DA
    Int J Pept Protein Res; 1976; 8(3):291-3. PubMed ID: 1279084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular dichroism of mammalian follitropins and the effects of treatment with N-bromosuccinimide.
    Giudice LC; Pierce JG; Cheng KW; Whitley R; Ryan RJ
    Biochem Biophys Res Commun; 1978 Apr; 81(3):725-33. PubMed ID: 666786
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparative oxidative conversion of protected peptide C alpha-hydrazides into the corresponding acids by N-bromosuccinimide.
    Meienhofer J; Dzieduszycka M; Smulkowski M; Makofske RC; Danho W
    Int J Pept Protein Res; 1981 Jul; 18(1):6-11. PubMed ID: 6796535
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of N-bromosuccinimide for the iodination of proteins for radioimmunoassay.
    Reay P
    Ann Clin Biochem; 1982 Mar; 19(Pt 2):129-33. PubMed ID: 7073216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of gamma-carboxyglutamyl peptide bonds by cyanogen bromide and by N-bromosuccinimide.
    Katayama K; Titani K
    FEBS Lett; 1978 Nov; 95(1):157-60. PubMed ID: 720597
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of modification with N-bromosuccinimide on the binding of ligands to dihydrofolate reductase.
    Thomson JW; Roberts GC; Burgen AS
    Biochem J; 1980 May; 187(2):501-6. PubMed ID: 7396859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodination of proteins and lipoproteins using N-bromosuccinimide as oxidizing agent.
    Sinn HJ; Schrenk HH; Friedrich EA; Via DP; Dresel HA
    Anal Biochem; 1988 Apr; 170(1):186-92. PubMed ID: 3389510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of protein kinase C with an N-bromosuccinimide-cleavage fragment of histone H1.
    Glynn B; Colliton J; McDermott J; Witters LA
    Biochem J; 1985 Oct; 231(2):489-92. PubMed ID: 4062909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide fragmentation suitable for solid-phase microsequencing. Use of N-bromosuccinimide and BNPS-skatole (3-bromo-3-methyl-2-[(2-nitrophenyl)thio]-3H-indole).
    Hunziker PE; Hughes GJ; Wilson KJ
    Biochem J; 1980 May; 187(2):515-9. PubMed ID: 7396860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacillus cereus beta-lactamase. Reaction with N-bromosuccinimide and the properties of the product.
    Ogawara H; Umezawa H
    Biochim Biophys Acta; 1975 Jun; 391(2):435-47. PubMed ID: 807248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective N-bromosuccinimide oxidation of the nonfluorescent tryptophan-31 in the active center of thioredoxin from Escherichia coli.
    Holmgren A
    Biochemistry; 1981 May; 20(11):3204-7. PubMed ID: 7018569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the N-bromosuccinimide inactivation of the enzyme rhodanese.
    Guido K; Horowitz P
    Biochim Biophys Acta; 1977 Nov; 485(1):95-100. PubMed ID: 911868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of bacteriorhodopsin with N-bromosuccinimide.
    Konishi T; Packer L
    FEBS Lett; 1977 Jul; 79(2):369-73. PubMed ID: 891952
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical modification of ribonucleic acid polymerase with N-bromosuccinimide.
    Wasylyk B; Malcolm AD
    Biochem Soc Trans; 1975; 3(5):654. PubMed ID: 1104389
    [No Abstract]   [Full Text] [Related]  

  • 20. N-bromosuccinimide-oxidized human serum albumin as a tool for the determination of drug binding sites of human serum albumin.
    Sakamoto H; Nagata I; Kikuchi K; Aida M; Irie M
    Chem Pharm Bull (Tokyo); 1983 Mar; 31(3):971-8. PubMed ID: 6883610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.